author-photo

R. Delarue

Bristol-Myers Squibb

2

Papers

16

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

THREE PHASE 1/2, OPEN-LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)-BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL)

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (16)